Investors

SEC Filings

SEC Filings

Filing date	Form	Description	Filing Group	View
April 22, 2011	D		Other	0001435049-11-000001.rtf View HTML 0001435049-11-000001.pdf 0001435049-11-000001.xls
December 05, 2011	D		Other	0001435049-11-000003.rtf View HTML 0001435049-11-000003.pdf 0001435049-11-000003.xls
November 17, 2009	D		Other	0001435049-09-000002.rtf View HTML 0001435049-09-000002.pdf 0001435049-09-000002.xls
November 17, 2009	D		Other	0001435049-09-000003.rtf View HTML 0001435049-09-000003.pdf 0001435049-09-000003.xls
April 09, 2010	D		Other	0001435049-10-000001.rtf View HTML 0001435049-10-000001.pdf 0001435049-10-000001.xls
February 12, 2013	D/A		Other	0001435049-13-000001.rtf View HTML 0001435049-13-000001.pdf 0001435049-13-000001.xls
September 10, 2013	D		Other	0001019687-13-003516.rtf View HTML 0001019687-13-003516.pdf 0001019687-13-003516.xls
June 13, 2014	D		Other	0001019687-14-002415.rtf View HTML 0001019687-14-002415.pdf 0001019687-14-002415.xls
January 05, 2015	D		Other	0001435049-15-000001.rtf View HTML 0001435049-15-000001.pdf 0001435049-15-000001.xls
August 21, 2023	15-12G	15-12G	Other	0001193125-23-216824.rtf View HTML 0001193125-23-216824.pdf 0001193125-23-216824.xls

Data provided by Kaleidoscope.

IR Contact

Novartis Investor Relations

investor.relations@novartis.com

MEDIA CONTACT

Novartis Media Relations

media.relations@novartis.com

Email Alerts

Required fields denoted by an asterisk ().

Alert type
SEC Alert
Calendar Alert
News Alert
Report Alert

Click here to unsubscribe from email alerts

© 2024 Chinook Therapeutics, Inc.. All rights reserved

Website Design: Hane Chow, Inc.